Long QT syndrome unmasked by dexmedetomidine: a case report

Congenit Heart Dis. 2014 Jan-Feb;9(1):E11-5. doi: 10.1111/chd.12055. Epub 2013 Mar 20.

Abstract

Dexmedetomidine is a selective alpha-2 adrenergic agonist that is used frequently for short-term sedation in children. It has been noted to cause hypertension, hypotension, bradycardia, and sinus pauses; however, QTc prolongation has not been reported with dexmedetomidine administration. We describe a case of marked QT prolongation with use of dexmedetomidine in a pediatric critical care setting. Clinicians should be vigilant about potential QT prolongation in patients on dexmedetomidine, particularly in those receiving multiple other medications.

Keywords: Dexmedetomidine; Pediatric Cardiology; Pediatric Critical Care; QT Prolongation.

Publication types

  • Case Reports

MeSH terms

  • Adrenergic alpha-2 Receptor Agonists / adverse effects*
  • Anti-Arrhythmia Agents / therapeutic use
  • Dexmedetomidine / adverse effects*
  • Electrocardiography
  • Humans
  • Hypnotics and Sedatives / adverse effects*
  • Infant
  • Long QT Syndrome / chemically induced*
  • Long QT Syndrome / diagnosis
  • Long QT Syndrome / drug therapy
  • Male
  • Risk Factors
  • Treatment Outcome

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Anti-Arrhythmia Agents
  • Hypnotics and Sedatives
  • Dexmedetomidine